Edition:
United States

Cynosure Inc (CYNO.OQ)

CYNO.OQ on NASDAQ Stock Exchange Global Select Market

66.25USD
23 Feb 2017
Change (% chg)

$-0.05 (-0.08%)
Prev Close
$66.30
Open
$66.25
Day's High
$66.50
Day's Low
$66.25
Volume
162,676
Avg. Vol
229,713
52-wk High
$66.65
52-wk Low
$37.82

Select another date:

Tue, Feb 14 2017

BRIEF-Cynosure agrees to termination fee of $57.7 mln for Hologic deal

* Hologic - upon termination of deal under specified circumstances Cynosure has agreed to pay co termination fee of about $57.7 million Source text - http://bit.ly/2kuOElN Further company coverage:

Hologic to buy Cynosure to expand into medical aesthetics

Hologic Inc said on Tuesday it would acquire medical aesthetics company Cynosure Inc for $1.65 billion as it looks to capitalize on an increase in medical procedures that are not traditionally reimbursed.

UPDATE 3-Hologic to buy Cynosure to expand into medical aesthetics

* Cynosure shares up 28 pct; Hologic down 3.6 pct (Adds analyst comments, details)

BRIEF-Hologic to acquire Cynosure for $1.65 bln

* Hologic to acquire Cynosure, leader in medical aesthetics systems and technologies, in all-cash tender offer that combines two complementary businesses

Hologic to buy Cynosure for $1.65 bln

Feb 14 Hologic Inc said on Tuesday that it would acquire medical aesthetics company Cynosure Inc for $1.65 billion.

BRIEF-Cynosure Q4 non-GAAP EPS $0.44

* Cynosure achieves record quarterly revenue of $122.1 million in the fourth quarter of 2016, up 19 percent year-over-year

BRIEF-Cynosure says entered into agreement to settle complaint filed by Arcare

* Cynosure Inc says on January 26, 2017, entered into an agreement to settle complaint filed by Arcare, Inc

BRIEF-Cynosure receives CFDA nod to market the Icon aesthetic system in China

* Cynosure receives CFDA clearance to market the Icon aesthetic system in China

BRIEF-Cynosure promotes Doug Delaney to CCO

* Cynosure promotes Doug Delaney to chief commercial officer Source text for Eikon: Further company coverage:

BRIEF-Cynosure posts Q3 non-gaap EPS of $0.29

* Cynosure announces record third-quarter revenues; revenues increase 36 percent from prior year to $106.4 million

Select another date:

More From Around the Web